{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:20:38Z","timestamp":1790032838946,"version":"4.0.1"},"reference-count":177,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2019,3,27]]},"abstract":"<jats:sec><jats:title\/><jats:p>Pseudomonas aeruginosa is a non-fermentative, gram-negative bacterium that is one of the most common pathogens responsible for hospital-acquired infections worldwide. The management of the infections caused by P. aeruginosa represents a huge challenge in the healthcare settings due to the increased emergence of resistant isolates, some of them resistant to all the currently available antimicrobials, which results in elevated morbimortality rates. Consequently, the development of new therapeutic strategies against multidrug-resistant P. aeruginosa is urgent and needful. P. aeruginosa is wellrecognized for its extreme genetic versatility and its ability to produce a lush variety of virulence factors. In this context, pseudolysin (or elastase B) outstands as a pivotal virulence attribute during the infectious process, playing multifunctional roles in different aspects of the pathogen-host interaction. This protein is a 33-kDa neutral zinc-dependent metallopeptidase that is the most abundant peptidase found in pseudomonal secretions, which contributes to the invasiveness of P. aeruginosa due to its ability to cleave several extracellular matrix proteins and to disrupt the basolateral intercellular junctions present in the host tissues. Moreover, pseudolysin makes P. aeruginosa able to overcome host defenses by the hydrolysis of many immunologically relevant molecules, including antibodies and complement components. The attenuation of this striking peptidase therefore emerges as an alternative and promising antivirulence strategy to combat antibiotic-refractory infections caused by P. aeruginosa. The anti-virulence approach aims to disarm the P. aeruginosa infective arsenal by inhibiting the expression\/activity of bacterial virulence factors in order to reduce the invasiveness of P. aeruginosa, avoiding the emergence of resistance since the proliferation is not affected. This review summarizes the most relevant features of pseudolysin and highlights this enzyme as a promising target for the development of new anti-virulence compounds.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389203720666190207100415","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T16:01:08Z","timestamp":1553788868000},"page":"471-487","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Anti-Virulence Strategy against the Multidrug-Resistant Bacterial Pathogen Pseudomonas aeruginosa: Pseudolysin (Elastase B) as a Potential Druggable Target"],"prefix":"10.2174","volume":"20","author":[{"given":"Anna Clara M.","family":"Galdino","sequence":"first","affiliation":[{"name":"Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus P.","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Department of Integrative Biology and Physiology, University of California, Los Angeles, CA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodorico C.","family":"Ramalho","sequence":"additional","affiliation":[{"name":"Departamento de Quimica, Universidade Federal de Lavras, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre A.","family":"de Castro","sequence":"additional","affiliation":[{"name":"Departamento de Quimica, Universidade Federal de Lavras, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta H.","family":"Branquinha","sequence":"additional","affiliation":[{"name":"Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 L.S.","family":"Santos","sequence":"additional","affiliation":[{"name":"Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"e00269","DOI":"10.1128\/mBio.00269-18","volume":"9","author":"La Rosa R.","year":"2018","unstructured":"La Rosa R, Johansen HK, Molin S. Convergent metabolic specialization through distinct evolutionary paths in","journal-title":"MBio"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003495-200767030-00003","volume":"67","author":"Driscoll J.A.","year":"2007","unstructured":"Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of infections.","journal-title":"Drugs"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","volume":"406","author":"Stover C.K.","year":"2000","unstructured":"Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV. Complete genome sequence of PAO1, an opportunistic pathogen.","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.3390\/antibiotics6040030","volume":"6","author":"Rupp\u00e9 E.","year":"2017","unstructured":"Rupp\u00e9 E, Cherkaoui A, Lazarevic V, Emonet S, Schrenzel J. Establishing genotype-to-phenotype relationships in bacteria causing hospital-acquired pneumonia: A prelude to the application of clinical metagenomics.","journal-title":"Antibiotics"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","volume":"22","author":"Oliver A.","year":"2015","unstructured":"Oliver A, Mulet X, L\u00f3pez-Causap\u00e9 C, Juan C. The increasing threat of high-risk clones.","journal-title":"Drug Resistance"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","volume":"22","author":"Lister P.D.","year":"2009","unstructured":"Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant : Clinical impact and complex regulation of chromosomally encoded resistance mechanisms.","journal-title":"Clin Microbiol Rev"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ajic.2016.08.007","volume":"44","author":"Rosenthal V.D.","year":"2016","unstructured":"Rosenthal VD, Al-Abdely HM, El-Kholy AA, AlKhawaja SAA, Leblebicioglu H, Mehta Y, Rai V, Hung NV, Kanj SS, Salama MF, Salgado-Yepez E, Elahi N, Morfin RO, Apisarnthanarak A, De Carvalho BM, Ider BE, Fisher D, Buenaflor MCSG, Petrov MM, Quesada-Mora AM, Zand F, Gurskis V, Anguseva T, Ikram A, de Moros DA, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di Silvestre G, Furova K, Ramos-Ortiz GY, Gamar Elanbya MO, Satari HI, Gupta U, Dendane T, Raka L, Guanche-Garcell H, Hu B, Padgett D, Jayatilleke K, Ben Jaballah N, Apostolopoulou E, Prudencio Leon WE, Sepulveda-Chavez A, Telechea HM, Trotter A, Alvarez-Moreno C, Kushner-Davalos L. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module.","journal-title":"Am J Infect Control"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archinte.159.10.1127","volume":"159","author":"Carmeli Y.N.","year":"1999","unstructured":"Carmeli YN, Troillet A, Karchmer W, Samore MH. Health and economic outcomes of antibiotic resistant","journal-title":"Arch Intern Med"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"526.e19","DOI":"10.1016\/j.amjmed.2005.11.029","volume":"119","author":"Gasink L.B.","year":"2006","unstructured":"Gasink LB, Fishman NO, Weiner MG, Nachamkin I, Bilker WB, Lautenbach E. Fluoroquinolone-resistant : Assessment of risk factors and clinical impact.","journal-title":"Am J Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/130.Supplement.S14","volume":"130","author":"Tapper M.L.","year":"1974","unstructured":"Tapper ML, Armstrong D. Bacteremia due to complicating neoplastic disease: A progress report.","journal-title":"J Infect Dis"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1201-9712(99)90017-6","volume":"3","author":"Todeschini G.","year":"1999","unstructured":"Todeschini G, Franchini M, Tecchio C, Meneghini V, Pizzolo G, Veneri D, Murari C, Ricetti MM, Perona G. Improved prognosis of bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.","journal-title":"Int J Infect Dis"},{"key":"ref=12","author":"Chatzinikolaou I.","unstructured":"Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV."},{"key":"ref=13","first-page":"e27","volume":"5","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y, Chen XL, Huang A, Liu S, Liu W, Zhang N, Lu X. Mortality attributable to carbapenem-resistant bacteremia: A meta-analysis of cohort studies.","journal-title":"Emerg Microbes Infect"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijid.2008.03.011","volume":"12","author":"Gir\u00e3o E.","year":"2008","unstructured":"Gir\u00e3o E, Levin AS, Basso M, Gobara S, Gomes LB, Medeiros EAS, Barone AA, Costa SF. Trends and outcome of 1121 nosocomial blood- stream infections in intensive care units in a Brazilian hospital, 1999\u20142008.","journal-title":"Int J Infect Dis"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/medicina46070071","volume":"46","author":"Vitkauskiene A.","year":"2010","unstructured":"Vitkauskiene A, Skrodeniene E, Dambrauskiene A, Macas A, Sakalauskas R. bacteremia: Resistance to antibiotics, risk factors, and patient mortality.","journal-title":"Medicina"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/AAC.00338-07","volume":"51","author":"Lodise T.P.","year":"2007","unstructured":"Lodise TP, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC. Predictors of 30-day mortality among patients with bloodstream infections: Impact of delayed appropriate antibiotic selection.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.21037\/jtd.2017.09.154","volume":"10","author":"Cheng V.","year":"2018","unstructured":"Cheng V, Abdul-Aziz MH, Roberts JA, Shekar K. Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.","journal-title":"J Thorac Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.05991-11","volume":"56","author":"Pe\u00f1a C.","year":"2012","unstructured":"Pe\u00f1a C, Suarez C, Gozalo M, Murillas J, Almirante B, Pomar V, Aguilar M. Granados. A.; Calbo, E.; Rodr\u00edguez-Ba\u00f1o, J.; Rodr\u00edguez, F.; Tubau, F.; Mart\u00ednez-Mart\u00ednez, L.; Oliver, A. Spanish Network for Research in Infectious Diseases REIPI: Prospective multicenter study of the impact of carbapenem resistance on mortality in bloodstream infections.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"fnx124","DOI":"10.1093\/femsle\/fnx124","volume":"364","author":"Newman J.W.","year":"2017","unstructured":"Newman JW, Floyd RV, Fothergill JL. The contribution of virulence factors and host factors in the establishment of urinary tract infections.","journal-title":"FEMS Microbiol Lett"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mib.2017.11.006","volume":"41","author":"Valentini M.","year":"2018","unstructured":"Valentini M, Gonzalez D, Mavridou DA, Filloux A. Lifestyle transitions and adaptive pathogenesis of","journal-title":"Curr Opin Microbiol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijmm.2010.08.008","volume":"300","author":"Hogardt M.","year":"2010","unstructured":"Hogardt M, Heesemann J. Adaptation of during persistence in the cystic fibrosis lung.","journal-title":"Int J Med Microbiol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/509821","volume":"195","author":"Hogardt M.","year":"2007","unstructured":"Hogardt M, Hoboth C, Schmoldt S, Henke C, Bader L, Heesemann J. Stage-specific adaptation of hypermutable isolates during chronic pulmonary infection in patients with cystic fibrosis.","journal-title":"J Infect Dis"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5604\/01.3001.0010.3792","volume":"71","author":"Al-Wrafy F.","year":"2017","unstructured":"Al-Wrafy F, Brzozowska E, G\u00f3rska S, Gamian A. Pathogenic factors of - the role of biofilm in pathogenicity and as a target for phage therapy.","journal-title":"Postepy Hig Med Dosw"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1164\/rccm.200408-1044SO","volume":"171","author":"Sadikot R.T.","year":"2005","unstructured":"Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in pneumonia.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.medmal.2005.10.007","volume":"36","author":"Kipnis E.","year":"2006","unstructured":"Kipnis E, Sawa T, Wiener-Kronish J. Targeting mechanisms of pathogenesis.","journal-title":"Med Mal Infect"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/mdr.2016.0144","volume":"23","author":"G\u00f3mez-Zorrilla S.","year":"2017","unstructured":"G\u00f3mez-Zorrilla S, Morandeira F, Castro MJ, Tubau F, Periche E, Ca\u00f1izares R, Dominguez MA, Ariza J, Pe\u00f1a C. acute inflammatory response of patients with infections: A prospective study.","journal-title":"Microb Drug Resist"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"pii:e00543","DOI":"10.1128\/mBio.00543-18","volume":"9","author":"Tseng B.","year":"2018","unstructured":"Tseng B, Reichhardt C, Merrihew G, Araujo-Hernandez S, Harrison JJ, MacCoss MJ, Parsek MR. A Biofilm matrix-associated protease inhibitor protects from proteolytic attack.","journal-title":"MBio"},{"key":"ref=28","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MB-0012-2014","volume":"3","author":"Roilides E.","year":"2015","unstructured":"Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. How biofilms evade host defenses.","journal-title":"Microbiol Spectr"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/mdr.2016.0087","volume":"23","author":"Hathroubi S.","year":"2017","unstructured":"Hathroubi S, Mekni MA, Domenico P, Nguyen D, Jacques M. Biofilms: Microbial shelters against antibiotics.","journal-title":"Microb Drug Resist"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-981-10-6141-7_16","volume":"Vol. 1","author":"Galdino A.C.M.","year":"2017","unstructured":"Galdino ACM, Branquinha MH, Santos ALS, Viganor LV. and its arsenal of proteases: Weapons to battle the host.","journal-title":"Pathophysiological aspects of proteases"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/2049-632X.12033","volume":"67","author":"Gellatly S.L.","year":"2013","unstructured":"Gellatly SL, Hancock REW. : New insights into pathogenesis and host defenses.","journal-title":"Pathog Dis"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2217\/fmb.15.100","volume":"10","author":"Crousilles A.","year":"2015","unstructured":"Crousilles A, Maunders E, Bartlett S, Fan C, Ukor EF, Abdelhamid Y, Baker Y, Floto A, Spring DR, Welch M. Which microbial factors really are important in infections?","journal-title":"Future Microbiol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcimb.2017.00039","volume":"7","author":"Moradali M.F.","year":"2017","unstructured":"Moradali MF, Ghods S, Rehm BH. lifestyle: A paradigm for adaptation, survival, and persistence.","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/nar\/gkm954","volume":"36","author":"Rawlings N.D.","year":"2008","unstructured":"Rawlings ND, Morton FR, Kok CY, Kong J, Barrett AJ. MEROPS: The peptidase database.","journal-title":"Nucleic Acids Res"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1016\/S0021-9258(18)49927-9","volume":"266","author":"Thayer M.M.","year":"1991","unstructured":"Thayer MM, Flaherty KM, McKay DB. Three-dimensional structure of the elastase of at 1.5-A resolution.","journal-title":"J Biol Chem"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1021\/bi00319a011","volume":"23","author":"Hangauer D.G.","year":"1984","unstructured":"Hangauer DG, Monzingo AF, Matthews BW. An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by -carboxymethyl dipeptides.","journal-title":"Biochemistry"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0006-291X(03)00084-6","volume":"301","author":"Tang B.","year":"2003","unstructured":"Tang B, Nirasawa S, Kitaoka M, Marie-Claire C, Hayashi K. General function of N-terminal propeptide on assisting protein folding and inhibiting catalytic activity based on observations with a chimeric thermolysin-like protease.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tibs.2004.02.004","volume":"29","author":"Yeats C.","year":"2004","unstructured":"Yeats C, Rawlings ND, Bateman A. The PepSY domain: A regulator of peptidase activity in the microbial environment?","journal-title":"Trends Biochem Sci"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0076-6879(95)48015-3","volume":"248","author":"Rawlings N.D.","year":"1995","unstructured":"Rawlings ND, Barrett AJ. Evolutionary families of metallopeptidases.","journal-title":"Methods Enzymol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0969-2126(98)00118-X","volume":"6","author":"Banbula A.","year":"1998","unstructured":"Banbula A, Potempa J, Travis J, Fernandez-Catalan C, Mann K, Huber R, Bode W, Medrano F. Amino-acid sequence and three-dimensional structure of the metalloproteinase at 1.72 A resolution.","journal-title":"Structure"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/jb.170.9.4309-4314.1988","volume":"170","author":"Bever A.","year":"1988","unstructured":"Bever A, Iglewski BH. Molecular characterization and nucleotide sequence of the elastase structural gene.","journal-title":"J Bacteriol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.enzmictec.2013.09.014","volume":"54","author":"Han M.","year":"2014","unstructured":"Han M, Wang X, Dingb H, Jinb M, Yub L, Wangb J, Yua X. The role of -glycosylation sites in the activity, stability, and expression of the recombinant elastase expressed by","journal-title":"Enzyme Microb Technol"},{"key":"ref=43","author":"Rawlings N.D.","year":"2012","unstructured":"Rawlings ND, Salvesen G.","journal-title":"Handbook of Proteolytic Enzymes"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1286-4579(00)00280-X","volume":"2","author":"Miyoshi S.","year":"2000","unstructured":"Miyoshi S, Shinoda S. Microbial metalloproteases and pathogenesis.","journal-title":"Microbes Infect"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/(SICI)1522-2683(19990601)20:7<1578::AID-ELPS1578>3.0.CO;2-U","volume":"20","author":"Viglio S.","year":"1999","unstructured":"Viglio S, Zanaboni G, Lupi A, Gianelli L, Luisetti M, Casali L, Cetta G, Iadarola P. Micellar electrokinetic chromatography for analyzing active site specificity of elastase.","journal-title":"Electrophoresis"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank.","journal-title":"Nucleic Acids Res"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0167-4838(89)90048-4","volume":"995","author":"Saulnier J.M.","year":"1989","unstructured":"Saulnier JM, Curtil FM, Duclos MC, Wallach JM. Elastolytic activity of elastase.","journal-title":"Biochim Biophys Acta"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"e9936","DOI":"10.1038\/srep09936","volume":"23","author":"Yang J.","year":"2015","unstructured":"Yang J, Zhao HL, Ran LY, Li CY, Zhang XY, Su HN, Shi M, Zhou BC, Chen XL, Zhang YZ. Mechanistic insights into elastin degradation by pseudolysin, the major virulence factor of the opportunistic pathogen","journal-title":"Sci Rep"},{"key":"ref=49","first-page":"529","volume":"132","author":"Bruce M.C.","year":"1985","unstructured":"Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF, Dearborn DG. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.","journal-title":"Am Rev Respir Dis"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/IAI.70.4.1783-1790.2002","volume":"70","author":"Erickson D.L.","year":"2002","unstructured":"Erickson DL, Endersby R, Kirkham A, Stuber K, Vollman DD, Rabin HR, Mitchell I, Storey DG. systems may control virulence factor expression in the lungs of patients with cystic fibrosis.","journal-title":"Infect Immun"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/IAI.51.1.115-118.1986","volume":"51","author":"Heck L.W.","year":"1986","unstructured":"Heck LW, Morihara K, McRae WB, Miller EJ. Specific cleavage of human type III and IV collagens by elastase.","journal-title":"Infect Immun"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1462-5822.2011.01606.x","volume":"13","author":"Beaufort N.","year":"2011","unstructured":"Beaufort N, Corvazier E, Hervieu A, Choqueux C, Dussiot M, Louedec L, Cady A, de Bentzmann S, Michel JB, Pidard D. The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic induces anoikis of human vascular cells.","journal-title":"Cell Microbiol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1111\/1462-2920.13262","volume":"18","author":"Reboud E.","year":"2016","unstructured":"Reboud E, Elsen S, Bouillot S, Golovkine G, Basso P, Jeannot K, Attr\u00e9e I, Huber P. Phenotype and toxicity of the recently discovered exlA-positive strains collected worldwide.","journal-title":"Environ Microbiol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s004080000031","volume":"178","author":"Azghani A.O.","year":"2000","unstructured":"Azghani AO, Miller EJ, Peterson BT. Virulence factors from increase lung epithelial permeability.","journal-title":"Lung"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"e75708","DOI":"10.1371\/journal.pone.0075708","volume":"8","author":"Beaufort N.","year":"2013","unstructured":"Beaufort N, Corvazier E, Mlanaoindrou S, de Bentzmann S, Pidard D. Disruption of the endothelial barrier by proteases from the bacterial pathogen : Implication of matrilysis and receptor cleavage.","journal-title":"PLoS One"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-15-21","volume":"15","author":"Nomura K.","year":"2014","unstructured":"Nomura K. Obata. K.; Keira; T.; Miyata, R.; Hirakawa, S.; Takano, K.; Kohno, T.; Sawada, N.; Himi, T.; Kojima, T. elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells.","journal-title":"Respir Res"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"e1003939","DOI":"10.1371\/journal.ppat.1003939","volume":"10","author":"Golovkine G.","year":"2014","unstructured":"Golovkine G, Faudry E, Bouillot S, Voulhoux R, Attr\u00e9e I, Huber P. VE-cadherin cleavage by LasB protease from facilitates type III secretion system toxicity in endothelial cells.","journal-title":"PLoS Pathog"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fcimb.2017.00532","volume":"7","author":"Golovkine G.","year":"2018","unstructured":"Golovkine G, Reboud E, Huber P. takes a multi-target approach to achieve junction breach.","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"e1005377","DOI":"10.1371\/journal.ppat.1005377","volume":"12","author":"Golovkine G.","year":"2016","unstructured":"Golovkine G, Faudry E, Bouillot S. Elsen. S.; Attr\u00e9e, I.; Huber, P. transmigrates at epithelial cell-cell junctions, exploiting sites of cell division and senescent cell extrusion.","journal-title":"PLoS Pathog"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1165\/rcmb.2010-0459OC","volume":"45","author":"Clark C.A.","year":"2011","unstructured":"Clark CA, Thomas LK, Azghani AO. Inhibition of protein kinase C attenuates elastase-induced epithelial barrier disruption.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0041-0101(01)00084-8","volume":"39","author":"Komori Y.","year":"2001","unstructured":"Komori Y, Nonogaki T. Nikai, Hemorrhagic activity and muscle damaging effect of metalloproteinase (elastase).","journal-title":"Toxicon"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1165\/rcmb.2004-0274OC","volume":"32","author":"Dulon S.","year":"2005","unstructured":"Dulon S, Leduc D, Cottrell GS, D\u2019Alayer J, Hansen KK, Bunnett NW, Hollenberg MD, Pidard D, Chignard M. elastase disables proteinase-activated receptor 2 in respiratory epithelial cells.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2005.11.002","volume":"5","author":"Pressler T.","year":"2006","unstructured":"Pressler T, Frederiksen B, Skov M, Garred P, Koch C, H\u00f8iby N. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of are risk factors for development of chronic lung infection-a case control study.","journal-title":"J Cyst Fibros"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/thorax.56.9.669","volume":"56","author":"Caballero E.","year":"2001","unstructured":"Caballero E, Drobnic ME, P\u00e9rez MT, Manresa JM, Ferrer A, Orriols R. Anti- antibody detection in patients with bronchiectasis without cystic fibrosis.","journal-title":"Thorax"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ppul.10380","volume":"36","author":"Lanotte P.","year":"2003","unstructured":"Lanotte P, Mereghetti L, Lejeune B, Massicot P, Quentin R. and cystic fibrosis: Correlation between exoenzyme production and patient\u2019s clinical state.","journal-title":"Pediatr Pulmonol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.001","volume":"128","author":"Suarez-Cuartin G.","year":"2017","unstructured":"Suarez-Cuartin G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, Perea L, Vidal S, Plaza V, Fardon TC, Sibila O, Chalmers JD. Anti- IgG antibodies and chronic airway infection in bronchiectasis.","journal-title":"Respir Med"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000181144","volume":"1","author":"Potempa J.","year":"2009","unstructured":"Potempa J, Pike RN. Corruption of innate immunity by bacterial proteases.","journal-title":"J Innate Immun"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/149.4.532","volume":"149","author":"Doring G.","year":"1984","unstructured":"Doring G, Dalhoff A, Vogel O, Brunner H, Droge U, Botzenhart K. activity of proteases of in a rat model.","journal-title":"J Infect Dis"},{"key":"ref=69","first-page":"728","volume":"114","author":"Bainbridge T.","year":"1989","unstructured":"Bainbridge T, Fick RB. Functional importance of cystic fibrosis immunoglobulin G fragments generated by elastase.","journal-title":"J Lab Clin Med"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4049\/jimmunol.144.6.2253","volume":"144","author":"Heck L.W.","year":"1990","unstructured":"Heck LW, Alarcon PG, Kulhavy RM, Morihara K, Russell MW, Mestecky JF. Degradation of IgA proteins by elastase.","journal-title":"J Immunol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1167\/iovs.07-1198","volume":"49","author":"Lomholt J.A.","year":"2008","unstructured":"Lomholt JA, Kilian M. Degradation of uniquely glycosylated secretory immunoglobulin A in tears from patients with keratitis.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"e27091","DOI":"10.1371\/journal.pone.0027091","volume":"6","author":"Kuang Z.","year":"2011","unstructured":"Kuang Z, Hao Y, Walling BE, Jeffries JL, Ohman DE, Lau GW. elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.","journal-title":"PLoS One"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1128\/IAI.58.9.3009-3014.1990","volume":"58","author":"Parmely M.","year":"1990","unstructured":"Parmely M, Gale A, Clabaugh M, Horvat R, Zhou WW. Proteolytic inactivation of cytokines by","journal-title":"Infect Immun"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/IAI.57.6.1668-1674.1989","volume":"57","author":"Horvat R.T.","year":"1989","unstructured":"Horvat RT, Clabaugh M, Duval-Jobe C, Parmely MJ. Inactivation of human gamma interferon by proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin.","journal-title":"Infect Immun"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1128\/IAI.56.7.1673-1677.1988","volume":"56","author":"Theander T.G.","year":"1988","unstructured":"Theander TG, Kharazmi A, Pedersen BK, Christensen LD, Tvede N, Poulsen LK, Odum N, Svenson M, Bendtzen K. Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by proteases.","journal-title":"Infect Immun"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/107999003766628151","volume":"23","author":"Leidal K.G.","year":"2003","unstructured":"Leidal KG, Munson KL, Johnson MC, Denning GM. Metalloproteases from degrade human RANTES, MCP-1, and ENA-78.","journal-title":"J Interferon Cytokine Res"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nrmicro2907","volume":"10","author":"Folkesson A.","year":"2012","unstructured":"Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, H\u00f8iby N, Molin S. Adaptation of to the cystic fibrosis airway: an evolutionary perspective.","journal-title":"Nat Rev Microbiol"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"e35648","DOI":"10.1371\/journal.pone.0035648","volume":"7","author":"Lor\u00e8 N.I.","year":"2012","unstructured":"Lor\u00e8 NI, Cigana C, De Fino I, Riva C, Juhas M, Schwager S, Eberl L, Bragonzi A. Cystic fibrosis-niche adaptation of reduces virulence in multiple infection hosts.","journal-title":"PLoS One"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"e1500199","DOI":"10.1126\/sciadv.1500199","volume":"1","author":"LaFayette S.L.","year":"2015","unstructured":"LaFayette SL, Houle D, Beaudoin T, Wojewodka G, Radzioch D, Hoffman LR, Burns JL, Dandekar AA, Smalley NE, Chandler JR, Zlosnik JE, Speert DP, Bernier J, Matouk E, Brochiero E, Rousseau S, Nguyen D. Cystic fibrosis-adapted mutants cause hyperinflammatory responses.","journal-title":"Sci Adv"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/IAI.10.1.128-135.1974","volume":"10","author":"Schultz D.R.","year":"1974","unstructured":"Schultz DR, Miller KD. Elastase of : Inactivation of complement components and complement-derived chemotactic and phagocytic factors.","journal-title":"Infect Immun"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1165\/rcmb.2002-0141OC","volume":"28","author":"Mariencheck W.I.","year":"2003","unstructured":"Mariencheck WI, Alcorn JF, Palmer SM. elastase degrades surfactant proteins A and D.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"e65797","DOI":"10.1371\/journal.pone.0065797","volume":"8","author":"Heimer S.R.","year":"2013","unstructured":"Heimer SR, Evans DJ, Mun JJ, Stern ME, Fleiszig SM. Surfactant protein D contributes to ocular defense against in a murine model of dry eye disease.","journal-title":"PLoS One"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/09273940701486423","volume":"15","author":"McCormick C.C.","year":"2007","unstructured":"McCormick CC, Hobden JA, Balzli CL, Reed JM, Caballero AR, Denard BS, Tang A, O\u2019Callaghan RJ. Surfactant protein D in keratitis.","journal-title":"Ocul Immunol Inflamm"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2958.2002.03146.x","volume":"46","author":"Schmidtchen A.","year":"2002","unstructured":"Schmidtchen A, Frick IM, Andersson E, Tapper H, Bj\u00f6rck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.","journal-title":"Mol Microbiol"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"e82240","DOI":"10.1371\/journal.pone.0082240","volume":"8","author":"Strempel N.","year":"2013","unstructured":"Strempel N, Neidig A, Nusser M, Geffers R, Vieillard J, Lesouhaitier O, Brenner-Weiss G, Overhage J. Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in","journal-title":"PLoS One"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/IAI.00939-15","volume":"84","author":"Casilag F.","year":"2015","unstructured":"Casilag F, Lorenz A, Krueger J, Klawonn F, Weiss S, H\u00e4ussler S. The LasB elastase of acts in concert with alkaline protease apra to prevent flagellin-mediated immune recognition.","journal-title":"Infect Immun"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2958.1998.00846.x","volume":"28","author":"Chakrabarty A.M.","year":"1988","unstructured":"Chakrabarty AM. Nucleoside diphosphate kinase: Role in bacterial growth, virulence, cell signalling and poly-saccharide synthesis.","journal-title":"Mol Microbiol"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1365-2958.1998.01121.x","volume":"30","author":"Kamath S.","year":"1998","unstructured":"Kamath S, Kapatral V, Chakrabarty AM. Cellular function of elastase in : role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis.","journal-title":"Mol Microbiol"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1099\/mic.0.037036-0","volume":"156","author":"Tielen P.","year":"2010","unstructured":"Tielen P, Rosenau F, Wilhelm S, Jaeger KE, Flemming HC, Wingender J. Extracellular enzymes affect biofilm formation of mucoid","journal-title":"Microbiology"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/JB.01623-06","volume":"189","author":"Overhage J.","year":"2007","unstructured":"Overhage J, Lewenza S, Marr AK, Hancock RE. Identification of genes involved in swarming motility using a PAO1 mini-Tn5-lux mutant library.","journal-title":"J Bacteriol"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1139\/cjm-2013-0667","volume":"60","author":"Yu H.","year":"2014","unstructured":"Yu H, He X, Xie W, Xiong J, Sheng H, Guo S, Huang C, Zhang D, Zhang K. Elastase LasB of promotes biofilm formation partly through rhamnolipid-mediated regulation.","journal-title":"Can J Microbiol"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/JB.01659-07","volume":"190","author":"Overhage J.","year":"2008","unstructured":"Overhage J, Bains M, Brazas MD, Hancock REW. Swarming of is a complex adaptation leading to increased production of virulence factors and antibiotic resistance.","journal-title":"J Bacteriol"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1365-2958.2003.03525.x","volume":"48","author":"Klausen M.","year":"2003","unstructured":"Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-J\u00f8rgensen A, Molin S, Tolker-Nielsen T. Biofilm formation by wild type, flagella and type IV pili mutants.","journal-title":"Mol Microbiol"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1128\/JB.182.21.5990-5996.2000","volume":"182","author":"K\u00f6hler T.","year":"2000","unstructured":"K\u00f6hler T, Curty LK, Barja F, van Delden C, Pech\u00e8re JC. Swarming of is dependent on cell-to-cell signaling and requires flagella and pili.","journal-title":"J Bacteriol"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1099\/mic.0.26280-0","volume":"149","author":"Cowell B.A.","year":"2003","unstructured":"Cowell BA, Twining SS, Hobden JA. Kwong. M.S.; Fleiszig, S.M. Mutation of and reduces invasion of epithelial cells.","journal-title":"Microbiology"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/IAI.64.1.37-43.1996","volume":"64","author":"Tang H.B.","year":"1996","unstructured":"Tang HB, DiMango E, Bryan R, Gambello M, Iglewski BH, Goldberg JB, Prince A. Contribution of specific virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.","journal-title":"Infect Immun"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1073\/pnas.96.5.2408","volume":"96","author":"Tan M.W.","year":"1999","unstructured":"Tan MW, Rahme LG, Sternberg JA, Tompkins RG, Ausubel FM. killing of used to identify virulence factors.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00134-017-4878-x","volume":"43","author":"Bassetti M.","year":"2017","unstructured":"Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: A visionary approach.","journal-title":"Intensive Care Med"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"Davies J.","year":"2010","unstructured":"Davies J, Davies D. Origins and evolution of antibiotic resistance.","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=100","first-page":"277","volume":"40","author":"Ventola C.L.","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis- part 1: Causes and threats.","journal-title":""},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-12-22","volume":"12","author":"Bassetti M.","year":"2013","unstructured":"Bassetti M, Merelli M, Temperoni C, Astilean A. New antibiotics for bad bugs: Where are we?","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"Tacconelli E.","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N. WHO Pathogens Priority List Working Group Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis.","journal-title":"Lancet Infect Dis"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","volume":"9","author":"Rasko D.A.","year":"2010","unstructured":"Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro1818","volume":"6","author":"Cegelski L.","year":"2008","unstructured":"Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies.","journal-title":"Nat Rev Microbiol"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ja.2016.138","volume":"70","author":"Culp E.","year":"2017","unstructured":"Culp E, Wrigh GD. Bacterial proteases, untapped antimicrobial drug target.","journal-title":"J Antibiot"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.aids.0000327510.68503.e8","volume":"22","author":"Quinn T.C.","year":"2008","unstructured":"Quinn TC. HIV epidemiology and the effects of antiviral therapy on long-term consequences.","journal-title":"AIDS"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.abb.2004.07.022","volume":"431","author":"Haq S.K.","year":"2004","unstructured":"Haq SK, Atif SM, Khan RH. Protein proteinase inhibitor genes in combat against insects, pests, and pathogens: Natural and engineered phytoprotection.","journal-title":"Arch Biochem Biophys"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/med.10007","volume":"22","author":"Supuran C.T.","year":"2002","unstructured":"Supuran CT, Scozzafava A, Clare BW. Bacterial protease inhibitors.","journal-title":"Med Res Rev"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1515\/bc.2011.044","volume":"392","author":"Kantyka T.","year":"2011","unstructured":"Kantyka T, Plaza K, Koziel J, Florczyk D, Stennicke HR, Thogersen IB, Enghild JJ, Silverman GA, Pak SC, Potempa J. Inhibition of cysteine proteases by human serpin potentially limits staphylococcal virulence.","journal-title":"Biol Chem"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/wound.2015.0673","volume":"5","author":"Suleman L.","year":"2016","unstructured":"Suleman L. Extracellular bacterial proteases in chronic wounds: A potential therapeutic target?","journal-title":"Adv Wound Care"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/AAC.00776-10","volume":"55","author":"Cathcart G.R.","year":"2011","unstructured":"Cathcart GR, Quinn D, Greer B, Harriott P, Lynas JF, Gilmore BF, Walker B. Novel inhibitors of the virulence factor LasB: A potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02789146","volume":"50","author":"Kocabiyik S.","year":"1995","unstructured":"Kocabiyik S, Ergin E, Turkoglu S. Effects of metals on elastase from SES-938-1.","journal-title":"Biol Trace Elem Res"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1128\/AAC.00511-10","volume":"54","author":"Aoki N.","year":"2010","unstructured":"Aoki N, Ishii Y, Tateda K, Saga T, Kimura S, Kikuchi Y, Kobayashi T, Tanabe Y, Tsukada H, Gejyo F, Yamaguchi K. Efficacy of calcium-EDTA as an inhibitor for metallo-\u03b2-lactamase in a mouse model of pneumonia.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1093\/ndt\/gfm342","volume":"22","author":"Lin-Tan D.T.","year":"2007","unstructured":"Lin-Tan DT, Lin JL, Yen TH, Chen KH, Huang YL. Long-term outcome of repeated lead chelation therapy in progressive non- diabetic chronic kidney diseases.","journal-title":"Nephrol Dial Transplant"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/IAI.38.2.716-723.1982","volume":"38","author":"Kessler E.","year":"1982","unstructured":"Kessler E, Israel M, Landshman N, Chechick A, Blumberg S. inhibition of elastase by metal-chelating peptide derivatives.","journal-title":"Infect Immun"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/ml300128f","volume":"3","author":"Garner A.L.","year":"2012","unstructured":"Garner AL, Struss AK, Fullagar JL, Agrawal A, Moreno AY, Cohen SM, Janda KD. 3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the virulence factor lasb.","journal-title":"ACS Med Chem Lett"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.chembiol.2015.03.012","volume":"22","author":"Zhu J.","year":"2015","unstructured":"Zhu J, Cai X, Harris TL, Gooyit M, Wood M, Lardy M, Janda KD. Disarming virulence factor LasB by leveraging a infection model.","journal-title":"Chem Biol"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acsinfecdis.8b00010","volume":"4","author":"Kany A.M.","year":"2018","unstructured":"Kany AM, Sikandar A, Haupenthal J, Yahiaoui S, Maurer CK, Proschak E, K\u00f6hnke J, Hartmann RW. Binding mode characterization and early evaluation of fragment-like thiols as inhibitors of the virulence factor lasB from","journal-title":"ACS Infect Dis"},{"key":"ref=119","author":"Kessler E.","unstructured":"Kessler E, Spierer A, Blumberg S."},{"key":"ref=120","first-page":"271","volume":"52","author":"Kawaharajo K.","year":"1982","unstructured":"Kawaharajo K, Homma JY, Aoyagi T, Umezawa H. Effect of phosphoramidon on protection against corneal ulcer caused by elastase and protease from","journal-title":"Jpn J Exp Med"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/02713688409011755","volume":"3","author":"Kessler E.","year":"1984","unstructured":"Kessler E, Spierer A. Inhibition by phosphoramidon of elastase injected intracorneally in rabbit eyes.","journal-title":"Curr Eye Res"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.mib.2009.01.005","volume":"12","author":"Williams P.","year":"2009","unstructured":"Williams P, Camara M. and environmental adaptation in : A tale of regulatory networks and multifunctional signal molecules.","journal-title":"Curr Opin Microbiol"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/JB.181.20.6264-6270.1999","volume":"181","author":"Anderson R.M.","year":"1999","unstructured":"Anderson RM, Zimprich CA, Rust L. A second operator is involved in elastase (lasB) activation.","journal-title":"J Bacteriol"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1128\/jb.178.22.6618-6622.1996","volume":"178","author":"Givskov M.","year":"1996","unstructured":"Givskov M, de Nys R, Manefield M, Gram L, Maximilien R, Eberl L, Molin S, Steinberg PD, Kjelleberg S. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling.","journal-title":"J Bacteriol"},{"key":"ref=125","first-page":"648257","volume":"2013","author":"Chu W.","year":"2013","unstructured":"Chu W, Zhou S, Jiang Y, Zhu W, Zhuang X. Fu. J. Effect of traditional Chinese herbal medicine with anti- activity on","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"879540","DOI":"10.1155\/2015\/879540","volume":"2015","author":"Husain F.M.","year":"2015","unstructured":"Husain FM, Ahmad I, Khan MS, Al-Shabib NA. (seed) extract interferes with regulated traits and biofilm formation in the strains of and","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"216097","DOI":"10.1155\/2015\/216097","volume":"2015","author":"Mustafi S.","year":"2015","unstructured":"Mustafi S, Veisaga ML, L\u00f3pez LA, Barbieri MA. A novel insight into dehydroleucodine mediated attenuation of virulence mechanism.","journal-title":"BioMed Res Int"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.3389\/fcimb.2017.00337","volume":"7","author":"Singh V.K.","year":"2017","unstructured":"Singh VK, Mishra A, Jha B. Anti- and anti-biofilm activity of extract by attenuating the -controlled virulence factor production in","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0971-5916.193295","volume":"144","author":"Gala V.C.","year":"2016","unstructured":"","journal-title":"Indian J Med Res"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"e0176883","DOI":"10.1371\/journal.pone.0176883","volume":"12","author":"Luo J.","year":"2017","unstructured":"Luo J, Dong B, Wang K, Cai S, Liu T, Cheng X, Lei D, Chen Y, Li Y, Kong J, Chen Y. Baicalin inhibits biofilm formation, attenuates the -controlled virulence and enhances clearance in a mouse peritoneal implant infection model.","journal-title":"PLoS One"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1099\/mic.0.064378-0","volume":"159","author":"Rasamiravaka T.","year":"2013","unstructured":"Rasamiravaka T, Jedrzejowski A, Kiendrebeogo M, Rajaonson S, Randriamampionona D, Rabemanantsoa C, Andriantsimahavandy A, Rasamindrakotroka A, Duez P, El Jaziri M, Vandeputte OM. Endemic species inhibit in PAO1.","journal-title":"Microbiology"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fitote.2015.02.002","volume":"102","author":"Kumar L.","year":"2015","unstructured":"Kumar L, Chhibber S, Kumar R, Kumar M, Harjai K. Zingerone silences and attenuates virulence of","journal-title":"Fitoterapia"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10529-012-1126-x","volume":"35","author":"Zhou L.","year":"2013","unstructured":"Zhou L, Zheng H, Tang Y, Yu W, Gong Q. Eugenol inhibits at sub-inhibitory concentrations.","journal-title":"Biotechnol Lett"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/08927014.2017.1350655","volume":"33","author":"Rathinam P.","year":"2017","unstructured":"Rathinam P, Vijay Kumar HS, Viswanathan P. Eugenol exhibits anti-virulence properties by competitively binding to receptors.","journal-title":"Biofouling"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1099\/mic.0.049338-0","volume":"157","author":"Vandeputte O.M.","year":"2011","unstructured":"Vandeputte OM, Kiendrebeogo M, Rasamiravaka T, St\u00e9vigny C, Duez P, Rajaonson S, Diallo B, Mol A, Baucher M, El Jaziri M. The flavanone naringenin reduces the production of -controlled virulence factors in PAO1.","journal-title":"Microbiology"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phymed.2014.10.006","volume":"22","author":"Gilabert M.","year":"2015","unstructured":"Gilabert M, Marcinkevicius K, Andujar S, Schiavone M, Arena ME, Bard\u00f3n A. Sesqui- and triterpenoids from the liverwort inhibitors of bacterial biofilm and elastase activity of human pathogenic bacteria.","journal-title":"Phytomedicine"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12275-015-4203-8","volume":"53","author":"Sepahi E.","year":"2015","unstructured":"Sepahi E, Tarighi S, Ahmadi FS, Bagheri A. Inhibition of in by two herbal essential oils from Apiaceae family.","journal-title":"J Microbiol"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"23347","DOI":"10.1038\/srep23347","volume":"6","author":"Das M.C.","year":"2016","unstructured":"Das MC, Sandhu P, Gupta P, Rudrapaul P, De UC, Tribedi P, Akhter Y, Bhattacharjee S. Attenuation of biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin.","journal-title":"Sci Rep"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"e0132791","DOI":"10.1371\/journal.pone.0132791","volume":"10","author":"Rasamiravaka T.","year":"2015","unstructured":"Rasamiravaka T, Vandeputte OM, Pottier L, Huet J, Rabemanantsoa C, Kiendrebeogo M, Andriantsimahavandy A, Rasamindrakotroka A, St\u00e9vigny C, Duez P, El Jaziri M. biofilm formation and persistence, along with the production of -dependent virulence factors, are disrupted by a triterpenoid coumarate ester isolated from , a tropical legume.","journal-title":"PLoS One"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/2049-632X.12039","volume":"68","author":"Garc\u00eda-Contreras R.","year":"2013","unstructured":"Garc\u00eda-Contreras R, Mart\u00ednez-V\u00e1zquez M, Vel\u00e1zquez Guadarrama N, Villegas Pa\u00f1eda AG, Hashimoto T, Maeda T, Quezada H, Wood TK. Resistance to the quorum-quenching compounds brominated furanone C-30 and 5-fluorouracil in clinical isolates.","journal-title":"Pathog Dis"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1099\/mic.0.052985-0","volume":"158","author":"Singh B.N.","year":"2012","unstructured":"Singh BN, Singh HB, Singh A, Singh BR, Mishra A, Nautiyal CS. fruit extract modulates -controlled virulence factor production and biofilm formation in","journal-title":"Microbiology"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/AAC.00612-07","volume":"52","author":"Adonizio A.","year":"2008","unstructured":"Adonizio A, Kong KF, Mathee K. inhibition of -controlled virulence factor production in by south florida plant extracts.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/AEM.01059-09","volume":"76","author":"Vandeputte O.M.","year":"2010","unstructured":"Vandeputte OM, Kiendrebeogo M, Rajaonson S, Diallo B, Mol A, El Jaziri M, Baucher M. Identification of catechin as one of the flavonoids from bark extract that reduces the production of -controlled virulence factors in PAO1.","journal-title":"Appl Environ Microbiol"},{"key":"ref=144","first-page":"321","volume":"13","author":"Zhang A.","year":"2017","unstructured":"Zhang A, Chu WH. anti- activity of forsythia suspense on and","journal-title":"Pharmacogn Mag"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3389\/fmicb.2017.00727","volume":"8","author":"Husain F.M.","year":"2017","unstructured":"Husain FM, Ahmad I, Al-Thubiani AS, Abulreesh HH, AlHazza IM, Aqil F. Leaf Extracts of Inhibit -regulated production of virulence factors and biofilm in test bacteria.","journal-title":"Front Microbiol"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"671562","DOI":"10.1155\/2015\/671562","volume":"2015","author":"Alasil S.M.","year":"2015","unstructured":"Alasil SM, Omar R, Ismail S, Yusof MY. Inhibition of -controlled virulence factors and biofilm formation in by culture extract from novel bacterial species of using a rat model of chronic lung infection.","journal-title":"Int J Bacteriol"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12038-011-9011-7","volume":"36","author":"Musthafa K.S.","year":"2011","unstructured":"Musthafa KS, Saroja V, Pandian SK, Ravi AV. Antipathogenic potential of marine . SS4 on -acyl-homoserine-lactone-mediated virulence factors production in (PAO1).","journal-title":"J Biosci"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/2049-632X.12124","volume":"70","author":"Christiaen S.E.","year":"2014","unstructured":"Christiaen SE, Matthijs N, Zhang XH, Nelis HJ, Bossier P, Coenye T. Bacteria that inhibit decrease biofilm formation and virulence in PAO1.","journal-title":"Pathog Dis"},{"key":"ref=149","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2018.03.031","volume":"118","author":"Pattnaik S.S.","year":"2018","unstructured":"Pattnaik SS, Ranganathan S, Ampasala DR, Syed A, Ameen F, Busi S. Attenuation of regulated virulence and biofilm development in PAO1 by SSP12.","journal-title":"Microb Pathog"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1164\/ajrccm\/148.4_Pt_1.1061","volume":"148","author":"Sakata K.","year":"1993","unstructured":"Sakata K, Yajima H, Tanaka K, Sakamoto Y, Yamamoto K, Yoshida A, Dohi Y. Erythromycin inhibits the production of elastase by without affecting its proliferation","journal-title":"Am Rev Respir Dis"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","volume":"57","author":"Imperi F.","year":"2013","unstructured":"Imperi F, Massai F, Ramachandran C, Longo F, Zennaro E, Rampioni G, Visca P, Leoni L. New life for an old drug: The anthelmintic drug niclosamide inhibits","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4103\/0971-5916.187114","volume":"143","author":"Gupta P.","year":"2016","unstructured":"Gupta P, Chhibber S, Harjai K. Sub-inhibitory concentration of ciprofloxacin targets system of causing inhibition of biofilm formation e reduction of virulence.","journal-title":"Indian J Med Res"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11274-013-1252-1","volume":"29","author":"Husain F.M.","year":"2013","unstructured":"Husain FM, Ahmad I. Doxycycline interferes with -mediated virulence factors and biofilm formation in gram-negative bacteria.","journal-title":"World J Microbiol Biotechnol"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3892\/etm.2014.2120","volume":"9","author":"","year":"2015","unstructured":". X, Z.G.; Gao, Y.; He, J.G.; Xu, W.F.; Jiang, M.; Jin, H.S. Effects of azithromycin on isolates from catheter-associated urinary tract infection.","journal-title":"Exp Ther Med"},{"key":"ref=155","first-page":"e180212","volume":"113","author":"Santos A.L.S.","year":"2018","unstructured":"Santos ALS, Galdino ACM, Mello TP, Ramos LS, Branquinha MH, Bolognese AM, Columbano J, Roudbary M. What are the advantages of living in a community? A microbial biofilm perspective!","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jac\/dkq036","volume":"65","author":"Alipour M.","year":"2010","unstructured":"Alipour M, Suntres ZE, Lafrenie RM, Omri A. Attenuation of virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes.","journal-title":"J Antimicrob Chemother"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"e1004852","DOI":"10.1371\/journal.pcbi.1004852","volume":"12","author":"Rodriguez-Esteban R.","year":"2016","unstructured":"Rodriguez-Esteban R. A drug-centric view of drug development: how drugs spread from disease to disease.","journal-title":"PLOS Comput Biol"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0033-1343430","volume":"63","author":"Ulusoy S.","year":"2013","unstructured":"Ulusoy S, Bosgelmez-Tinaz G. Nonsteroidal anti-inflammatory drugs reduce the production of regulated virulence factors and swarm in motility in human pathogen","journal-title":"Drug Res"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1128\/IAI.73.9.5319-5328.2005","volume":"73","author":"Prithiviraj B.","year":"2005","unstructured":"Prithiviraj B, Bais HP, Weir T, Suresh B, Najarro EH, Dayakar BV, Schweizer HP, Vivanco JM. Down regulation of virulence factors of by salicylic acid attenuates its virulence on and","journal-title":"Infect Immun"},{"key":"ref=160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.micpath.2014.07.008","volume":"74","author":"El-Mowafy S.A.","year":"2014","unstructured":"El-Mowafy SA, Galil KH, El-Messery SM, Shaaban MI. Aspirin is an efficient inhibitor of , virulence and toxins in","journal-title":"Microb Pathog"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4314\/ahs.v17i3.24","volume":"17","author":"Abbas H.A.","year":"2017","unstructured":"Abbas HA, Elsherbini AM, Shaldam MA. Repurposing metformin as a inhibitor in","journal-title":"Afr Health Sci"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1128\/AAC.00665-06","volume":"50","author":"M\u00fch U.","year":"2006","unstructured":"M\u00fch U, Schuster M, Heim R, Singh A, Olson ER, Greenberg EP. Novel inhibitors identified in an ultra-high-throughput screen.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1365-2672.2010.04751.x","volume":"109","author":"Xu G.","year":"2010","unstructured":"Xu G, Xiong W, Hu Q, Zuo P, Shao B, Lan F, Lu X, Xu Y, Xiong S. Lactoferrin-derived peptides and lactoferricin chimera inhibit virulence factor production and biofilm formation in","journal-title":"J Appl Microbiol"},{"key":"ref=164","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1099\/00221287-148-6-1709","volume":"148","author":"Laux D.C.","year":"2002","unstructured":"Laux DC, Corson JM, Givskov M, Hentzer M, M\u00f8ller A, Wosencroft KA, Olson JC, Krogfelt KA, Goldberg JB, Cohen PS. Lysophosphatidic acid inhibition of the accumulation of PAO1 alginate, pyoverdin, elastase and LasA.","journal-title":"Microbiology"},{"key":"ref=165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.colsurfb.2010.04.014","volume":"79","author":"Kalishwaralal K.","year":"2010","unstructured":"Kalishwaralal K. BarathManiKanth, S.; Pandian, S.R.; Deepak, V.; Gurunathan, S. Silver nanoparticles impede the biofilm formation by and","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.2147\/IJN.S141201","volume":"12","author":"Ali S.S.","year":"2017","unstructured":"Ali SS, Morsy R, El-Zawawy NA, Fareed MF, Bedaiwy MY. Synthesized zinc peroxide nanoparticles (ZnO-NPs): a novel antimicrobial, anti-elastase, anti-keratinase, and anti-inflammatory approach toward polymicrobial burn wounds.","journal-title":"Int J Nanomedicine"},{"key":"ref=167","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/lam.12456","volume":"61","author":"Garc\u00eda-Lara B.","year":"2015","unstructured":"Garc\u00eda-Lara B, Saucedo-Mora MA, Roldan-Sanchez JA, P\u00e9rez-Eretza B, Ramasamy M, Lee J, Coria-Jimenez R, Tapia M, Vareia-Guerrero V, Garc\u00eda-Conteras R. Inhibition of -dependent virulence factors and biofilm formation of clinical and environmental strains by ZnO nanoparticles.","journal-title":"Lett Appl Microbiol"},{"key":"ref=168","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.colsurfb.2009.05.018","volume":"73","author":"Jha A.K.","year":"2009","unstructured":"Jha AK, Orasad K, Prasad K, Kulakarni AR. Plant system: Natures nanofactory.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"36761","DOI":"10.1038\/srep36761","volume":"6","author":"Al-Shabib N.A.","year":"2016","unstructured":"Al-Shabib NA, Husain FM, Ahmed F, Khan RA, Ahmad I, Alsharaeh E, Khan MS, Hussain A, Rehman MT, Yusuf M, Hassan I, Khan JM, Ashraf GM, Alsalme A, Al-Ajmi MF, Tarasov VV, Aliev G. Biogenic synthesis of Zinc oxide nanostructures from seed: Prospective role as food packaging material inhibiting broad-spectrum and biofilm.","journal-title":"Sci Rep"},{"key":"ref=170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fcimb.2017.00093","volume":"7","author":"Prateeksha A.","year":"2017","unstructured":"Prateeksha A, Singh BR, Shoeb M, Sharma S, Naqvi AH, Gupta VK, Singh BN. Scaffold of selenium nanovectors and honey phytochemicals for inhibition of and biofilm formation.","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"13719","DOI":"10.1038\/srep13719","volume":"5","author":"Singh B.R.","year":"2015","unstructured":"Singh BR, Singh BN, Singh A, Khan W, Naqvi AH, Singh HB. Mycofabricated biosilver nanoparticles interrupt systems.","journal-title":"Sci Rep"},{"key":"ref=172","doi-asserted-by":"crossref","first-page":"e01929","DOI":"10.1128\/AAC.01929-18","volume":"63","author":"Chojnacki M.","year":"2018","unstructured":"Chojnacki M, Philbrick A, Wucher B, Reed JN, Tomaras A, Dunman PM, Wozniak RAF. Antibiotic resistance in and alternative therapeutic options.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tips.2017.01.004","volume":"38","author":"Johnson B.K.","year":"2017","unstructured":"Johnson BK, Abramovitch RB. Small molecules that sabotage bacterial virulence.","journal-title":"Trends Pharmacol Sci"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eimc.2016.06.015","volume":"35","author":"Galdino A.C.M.","year":"2017","unstructured":"Galdino ACM, Viganor L, Ziccardi M, Nunes APF, Dos Santos KRN, Branquinha MH, Santos ALS. Hterogeneous production of proteases from Brazilian clinical isolates of","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref=177","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1099\/jmm.0.018283-0","volume":"59","author":"Bradbury R.S.","year":"2010","unstructured":"Bradbury RS, Roddam LF, Merritt A, Reid DW, Champion AC. Virulence gene distribution in clinical, nosocomial and environmental isolates of","journal-title":"J Med Microbiol"},{"key":"ref=178","first-page":"7243","volume":"18","author":"Holban A.M.","year":"2013","unstructured":"Holban AM, Chifiriuc MC, Cotar AI, Bleotu C, Grumezescu AM, Banu O, Grumezescu AM, Banu O. lazar, V. Virulence markers in isolates from hospital and acquired infections occurred in patients with underlying cardiovascular disease.","journal-title":"Rom Biotechnol Lett"},{"key":"ref=179","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/000155501317208336","volume":"81","author":"Schmidtchen A.","year":"2001","unstructured":"Schmidtchen A, Wolff H, Hansson C. Differential proteinase expression by derived from chronic leg ulcers.","journal-title":"Acta Derm Venereol"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:05:46Z","timestamp":1694736346000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169743\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":177,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,3,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389203720666190207100415","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}